
201 - 500 employees
Founded 2003
🧬 Biotechnology
💊 Pharmaceuticals
🔥 Funding within the last year
💰 $500M Post-IPO Equity - Summit Therapeutics on 2025-10
Biotechnology • Pharmaceuticals
Summit Therapeutics, Inc. is a biopharmaceutical oncology company focused on the discovery, development, and commercialization of novel medicinal therapies to improve quality and duration of life for patients with serious unmet medical needs. The company is advancing ivonescimab (SMT112), a novel bispecific antibody targeting PD-1 and VEGF, through multiple Phase 3 clinical trials for non-small cell lung cancer and other solid tumors under license from Akeso. Summit emphasizes clinical development, regulatory filing strategies, and potential commercialization in its licensed territories while promoting patient- and caregiver-friendly treatment options.
🔥 1 minute ago
Improve your chances of getting an interview by checking your resume score before you apply.

201 - 500 employees
Founded 2003
🧬 Biotechnology
💊 Pharmaceuticals
🔥 Funding within the last year
💰 $500M Post-IPO Equity - Summit Therapeutics on 2025-10
Biotechnology • Pharmaceuticals
Summit Therapeutics, Inc. is a biopharmaceutical oncology company focused on the discovery, development, and commercialization of novel medicinal therapies to improve quality and duration of life for patients with serious unmet medical needs. The company is advancing ivonescimab (SMT112), a novel bispecific antibody targeting PD-1 and VEGF, through multiple Phase 3 clinical trials for non-small cell lung cancer and other solid tumors under license from Akeso. Summit emphasizes clinical development, regulatory filing strategies, and potential commercialization in its licensed territories while promoting patient- and caregiver-friendly treatment options.
• Independently cultivate and manage relationships with PBDMs, acting as primary point of contact and collaborating closely with other field roles to ensure an aligned approach to stakeholder engagement • Collaborate with internal HEOR team and market access team, to execute on scientific engagement strategy for appropriate stakeholders (e.g., Payers, PBMs, GPOs, IDNs and Oncology Pathways) within a territory or customer base • Serve as a conduit and resource for providing clinical and healthcare economic information (HCEI) to payers and formulary decision-makers • Maintaining required knowledge of ivonescimab, to proactively and reactively communicate clinical and economic information related to ivonescimab to advance formulary decision-making and improve patient outcomes • Capture and communicate internally key stakeholder insights and evidence gaps/needs including potential opportunities for collaboration • Understand the medical affairs priorities to contribute to content strategy development and execute aligned field tactics • Work with stakeholders to ensure inclusion of ivonescimab in clinical/payer pathways, and treatment order sets, while optimizing budget assessments. • Collaborate effectively with medical affairs, HEOR, market access and other colleagues as appropriate in support of developing and implementing account engagement plan, providing input on scientific and value topics • Understanding of principles of study design, methodology, data analysis, and interpretation to successfully communicate data to stakeholders • Utilize and effectively present clinical, humanistic, and economic evidence as well as the value proposition in a clear and compelling manner to the payer audience • Maintain understanding of market and payer needs in an increasingly complex and dynamic environment to drive actionable recommendations to inform medical and market access strategy • All other duties as assigned
• Bachelor’s degree required. • MD, PharmD, or PhD in Health Services Research, Health Economics, or related field. Masters preferred. • 12+ years relevant experience in healthcare industry with 5+ years direct experience in the pharmaceutical, managed care, or consulting industries • Previous experience in Oncology, preferably non-small cell lung cancer (NSCLC) • Previous experience in field-based role with strong understanding of the US healthcare system, market access landscape and value-based decision makers • Experience analyzing health care data and utilizing real-world evidence (RWE) is a plus • Strong analytical capabilities and excellent communication skills, including ability to communicate large amounts of scientific information in a manner that is clear, concise and memorable • Ability to work collaboratively across diverse teams and manage multiple stakeholders with ability to influence and collaborate to make a business impact • Ability to be proactive, enthusiastic and goal oriented • Travel up to approximately 75% of time, including overnight travel for internal and external meetings
• .
Apply Now🔥 6 minutes ago
Director of Corporate Sales responsible for environmental solutions growth at WM. Collaborating with sales teams and analyzing data to drive results.
🔥 12 minutes ago
Executive Director leading the RAPID Manufacturing Institute for process intensification in partnership with DOE. Overseeing growth strategy, team management, and strategic partnerships for industrial relevance.
🔥 25 minutes ago
Regional Director providing sales leadership and operational oversight of OCLC's library services. Focusing on achieving sales quotas, developing strategies, and fostering high-performing sales teams.
🔥 48 minutes ago
Regional Business Director at Caris leading sales growth strategy in oncology. Responsible for managing and developing sales teams across Central North region.
🔥 2 hours ago
Director of Enterprise Accounts leading strategic relationships for Medtronic. Driving business strategies and collaborating with senior leadership to maintain market share and growth.